Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”

Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju Seog Lee

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)e84-e86
JournalClinical and Molecular Hepatology
Volume31
Issue number1
DOIs
StatePublished - Jan 2025

Keywords

  • Biomarker
  • Immunotherapy
  • Liver cancer

ASJC Scopus subject areas

  • Hepatology
  • Molecular Biology

Cite this